SANUWAVE Health, Inc.
SNWVNasdaq
$6.39
↓ -3.9%Jul 17 close · end-of-day
Price
1Y↓ -81.8%
End-of-day closes; the latest point is the live 15-min-delayed price · split & dividend adjusted · chart by TradingView
Key statistics
Market Cap
$54.9M
Enterprise Value
$64.6M
P/E
6.7
P/S
1.2
P/B
29.9
EV/EBITDA
15.1
PEG
—
FCF Yield
7.3%
Dividend Yield
—
Revenue (TTM)
$44.3M
Net Income (TTM)
$16.5M
Free Cash Flow (TTM)
$4.0M
Gross Margin
76.7%
Operating Margin
7.3%
Net Margin
37.2%
ROE
897.3%
ROIC
22.0%
Debt / Equity
11.2
Net Cash
-$9.7M
Return 1Y
-82.9%
Company profile
SANUWAVE Health, Inc. researches, develops, and commercializes noninvasive, high-energy, and acoustic shock waves for regenerative medicine. The company's lead regenerative product is the dermaPACE device for treating diabetic foot ulcers. Its portfolio of healthcare products and product candidates activate biologic signaling and angiogenic responses.
- Sector
- Manufacturing
- Industry
- Medical Equipment
- Employees
- 40
- Headquarters
- Georgia
- Website
- sanuwave.com
Earnings
SNWV Q1 2026 Earnings
Period ends 2026-03-31
MetricActualYoY
Revenue$9.6M↑ +3.1%
Diluted EPS-$0.17↓ -76.4%
Actuals from SEC filings; YoY vs the year-ago quarter. Analyst estimates & surprise require a data feed (coming soon).
Financial statements
| Line item | FY2020 | FY2021 | FY2022 | FY2023 | FY2024 | FY2025 |
|---|---|---|---|---|---|---|
| Revenue | $4.1M | $13.0M | $16.7M | $20.4M | $32.6M | $44.1M |
| Gross profit | $2.9M | $8.0M | $12.4M | $14.4M | $24.6M | $34.0M |
| Operating income | -$25.2M | -$14.1M | -$9.0M | -$540,000.00 | $3.8M | $4.9M |
| Net income | -$30.9M | -$27.3M | -$10.3M | -$25.8M | -$33.1M | $11.8M |
| Diluted EPS | -$0.08 | -$0.05 | -$0.02 | -$12.19 | -$7.41 | $0.41 |
| Operating cash flow | -$12.7M | -$6.4M | -$17.2M | -$4.5M | $2.5M | $3.9M |
| Free cash flow | -$12.8M | -$6.9M | — | -$4.5M | $2.0M | $1.9M |
| Gross margin | 71.4% | 61.7% | 74.1% | 70.4% | 75.2% | 77.1% |
| Operating margin | -621.1% | -108.7% | -53.5% | -2.6% | 11.8% | 11.2% |
| Net margin | -762.6% | -209.5% | -61.5% | -126.5% | -101.4% | 26.8% |
| Line item | Q2 '24 | Q3 '24 | Q4 '24 | Q1 '25 | Q2 '25 | Q3 '25 | Q4 '25 | Q1 '26 |
|---|---|---|---|---|---|---|---|---|
| Revenue | $7.2M | $9.4M | $10.3M | $9.3M | $10.1M | $11.3M | $13.4M | $9.6M |
| Gross profit | $5.2M | $7.1M | $8.0M | $7.4M | $7.8M | $8.7M | $10.0M | $7.4M |
| Operating income | $1.6M | $1.5M | $2.0M | $601,000.00 | $1.4M | $903,000.00 | $2.0M | -$1.1M |
| Net income | $6.2M | -$21.2M | -$13.3M | -$6.1M | $551,000.00 | $9.7M | $7.7M | -$1.4M |
| Diluted EPS | $0.00 | -$6.65 | -$0.76 | -$0.72 | -$0.04 | $0.39 | $0.78 | -$0.17 |
| Operating cash flow | -$668,000.00 | $1.3M | $741,000.00 | -$1.5M | $993,000.00 | $1.1M | $3.3M | $397,000.00 |
| Free cash flow | -$760,000.00 | $1.2M | $505,000.00 | -$1.7M | -$166,000.00 | $556,000.00 | $3.2M | $374,000.00 |
| Gross margin | 73.2% | 75.5% | 77.9% | 79.0% | 78.1% | 77.6% | 74.7% | 77.3% |
| Operating margin | 23.0% | 15.8% | 19.5% | 6.4% | 14.3% | 8.0% | 15.0% | -11.7% |
| Net margin | 86.4% | -226.1% | -128.9% | -65.6% | 5.5% | 86.0% | 57.4% | -15.0% |
Company news
Jun 16, 2026
May 13, 2026
- 67d agoSANUWAVE Health Inc (SNWV) Q1 2026 Earnings Call Highlights: Record Revenue Amid Market Challengesfinance.yahoo.com
- 68d agoSanuwave Health Q1 Earnings Call Highlightsmarketbeat.com
- 68d agoSANUWAVE Health Inc Reports Q1 2026 Results: Full Earnings Call Transcriptfinance.yahoo.com
- 68d agoSANUWAVE Health, Inc. Q1 2026 Earnings Call Summaryapp.moby.co
May 12, 2026
Analyst estimates
Coming soonConsensus revenue & EPS estimates and price targets will appear here once a forward-estimates data feed is connected.
Insider transactions
BoughtSoldMonthly insider $ volume · trailing 12 months
| Date | Insider | Type | Shares | Price | Value | Filing |
|---|---|---|---|---|---|---|
| 2026-05-01 | Opaleye Management Inc. | Sale | 10,081 | $16.11 | $162,409.95 | filing |
| 2026-05-01 | Opaleye Management Inc. | Sale | 500 | $16.11 | $8,055.25 | filing |
| 2026-04-30 | Opaleye Management Inc. | Sale | 24,000 | $16.15 | $387,624.00 | filing |
| 2026-04-30 | Opaleye Management Inc. | Sale | 1,000 | $16.15 | $16,151.00 | filing |
| 2026-04-29 | Opaleye Management Inc. | Sale | 23,360 | $17.25 | $402,903.94 | filing |
| 2026-04-29 | Opaleye Management Inc. | Sale | 1,000 | $17.25 | $17,247.60 | filing |
| 2026-04-28 | Opaleye Management Inc. | Sale | 43,788 | $18.47 | $808,650.51 | filing |
| 2026-04-28 | Opaleye Management Inc. | Sale | 2,500 | $18.47 | $46,168.50 | filing |
| 2026-04-21 | Opaleye Management Inc. | Sale | 202 | $20.50 | $4,141.51 | filing |
| 2026-04-17 | Opaleye Management Inc. | Sale | 11,267 | $20.46 | $230,535.21 | filing |
| 2026-04-17 | Opaleye Management Inc. | Sale | 5,000 | $20.46 | $102,305.50 | filing |
| 2025-12-12 | MANCHESTER MANAGEMENT CO LLC | Sale | 6,500 | $21.04 | $136,788.60 | filing |
| 2025-12-11 | MANCHESTER MANAGEMENT CO LLC | Sale | 13,500 | $31.28 | $422,277.30 | filing |
| 2025-12-10 | MANCHESTER MANAGEMENT CO LLC | Sale | 8,625 | $30.39 | $262,129.28 | filing |
| 2025-12-09 | MANCHESTER MANAGEMENT CO LLC | Sale | 8,785 | $30.58 | $268,678.68 | filing |
| 2025-12-08 | MANCHESTER MANAGEMENT CO LLC | Sale | 125,400 | $30.75 | $3.9M | filing |
| 2025-12-08 | MANCHESTER MANAGEMENT CO LLC | Sale | 2,000 | $31.60 | $63,203.40 | filing |
| 2025-10-06 | Opaleye Management Inc. | Buy | 1,267 | $30.28 | $38,360.96 | filing |
Latest 18 transactions.
Fundamentals & filings from SEC EDGAR. Prices adjusted for splits & dividends. Not investment advice.